All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Stanford University Dr. Theo D. Palmer PhD Tools and Technologies II Development of small molecule screens for autism using patient-derived iPS cells $1,797,606
University of California, Berkeley Dr. Steven M. Conolly Tools and Technologies II Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo $1,311,596
University of California, San Diego Shu Chien Tools and Technologies II Development of Synthetic Microenvironments for Stem Cell Growth and Differentiation $1,706,628
University of California, Los Angeles Dr. Thomas Carmichael M.D., Ph.D. Tools and Technologies II Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke $1,825,613
Stanford University Dr. Michele Calos Tools and Technologies II Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation $1,592,897
Fluidigm Corporation Dr. Marc A Unger Tools and Technologies II Development and Application of Versatile, Automated, Microfluidic Cell Culture System $1,939,236
University of California, Los Angeles Dr. Martin Gabriel Martin Tools and Technologies II Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders $1,783,250
University of California, Los Angeles Dr. Sophie X Deng Early Translational II Regeneration of Functional Human Corneal Epithelial Progenitor Cells $697,507
University of California, San Francisco Dr. Arturo Alvarez-Buylla Early Translational II Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy $1,564,016
University of California, Davis Dr. Mark Zern Early Translational II Liver Cell Transplantation $4,212,621
Stanford University Dr. Michele Calos Early Translational II Stem Cell Therapy for Duchenne Muscular Dystrophy $2,267,261
University of California, Irvine Dr. Brian J. Cummings Early Translational II Neural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury $1,517,767
University of California, Los Angeles Dr. Sophie X Deng Early Translational II Regeneration of Functional Human Corneal Epithelial Progenitor Cells $1,524,947
Cedars-Sinai Medical Center Dr. Dan Gazit Early Translational II Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures $1,927,698
University of California, Los Angeles Leif Havton Early Translational II Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons $75,628
University of California, Irvine Leif A Havton Early Translational II Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons $1,527,011
City of Hope, Beckman Research Institute Dr. Yanhong Shi Ph.D. Early Translational II Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell $1,835,983
City of Hope, Beckman Research Institute Dr. David Louis DiGiusto Early Translational II Development of RNA-based approaches to stem cell gene therapy for HIV $3,097,160
University of California, Davis Dr. Roslyn Rivkah Isseroff Early Translational II Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds $4,629,747
University of California, Los Angeles Dr. Noriyuki Kasahara Early Translational II Stem cell-based carriers for RCR vector delivery to glioblastoma $3,340,625
Salk Institute for Biological Studies Dr. Fred H Gage Early Translational II Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model $2,472,839
University of California, Irvine Dr. Henry John Klassen Early Translational II Human retinal progenitor cells as candidate therapy for retinitis pigmentosa $1,803,768
Children’s Hospital of Los Angeles Dr. Markus Muschen Early Translational II Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication $850,769
University of California, San Francisco Markus Muschen Early Translational II Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication $2,756,536
Buck Institute for Age Research Dr. Xianmin Zeng Early Translational II Banking transplant ready dopaminergic neurons using a scalable process $4,983,013
iPierian, Inc. Dr. John Dimos Early Translational II New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells $2,410,000
University of California, Los Angeles Prof. Bruno Peault Early Translational II Harnessing native fat-residing stem cells for bone regeneration $5,359,076
Scripps Research Institute Peter G. Schultz Early Translational II Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis $6,047,249
University of California, San Diego Professor Alysson R Muotri Early Translational II Developing a drug-screening system for Autism Spectrum Disorders using human neurons $1,376,198
University of California, Irvine Dr. Leslie M Thompson Early Translational II A hESc-based Development Candidate for Huntington’s Disease $3,955,038
University of California, San Diego Catriona Jamieson Early Translational II Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy $3,103,041
Gladstone Institutes, J. David Dr. Todd C. McDevitt Research Leadership Engineering microscale tissue constructs from human pluripotent stem cells $5,849,100
University of California, Los Angeles Dr. John P Chute Research Leadership Niche-Focused Research: Discovery & Development of Hematopoietic Regenerative Factors $4,645,297
University of California, Berkeley Dr. Xavier Darzacq Research Leadership Single Molecule Biophysics and Biology of Cellular Identity $4,175,924
University of California, San Francisco Redacted Research Leadership Recapitulating development of the musculoskeletal axis in vitro with pluripotent cells $0
University of California, San Diego Dr. Eric T. Ahrens Research Leadership Molecular Imaging for Stem Cell Science and Clinical Application $5,680,474
University of California, Santa Cruz Professor Richard Gregory Research Leadership MicroRNA Regulation in Stem Cells, Development, and Disease $0
Stanford University Professor Hiromitsu Nakauchi Research Leadership Generation of functional cells and organs from iPSCs $5,426,135
Gladstone Institutes, J. David Dr. Kevin Kit Parker PhD Research Leadership Engineering Cardiac Tissue for Regeneration and Drug Development $0
Cedars-Sinai Medical Center Dr. Barry R Stripp Research Leadership Epithelial progenitors and the stromal niche as therapeutic targets in lung disease $4,841,830
Parkinson’s Institute Dennis Steindler Research Leadership Stem Cell Pathologies in Parkinson’s disease as a key to Regenerative Strategies $0
University of Southern California Dr. Andrew McMahon Research Leadership Repair and regeneration of the nephron $5,672,206
University of California, Berkeley Dr. Zhigang He Research Leadership Developing a regeneration-based functional restoration treatment for spinal cord injury $0
University of California, Santa Barbara Professor Peter J Coffey Research Leadership Development of Cellular Therapies for Retinal Disease $4,690,963
Sanford Burnham Prebys Medical Discovery Institute Dr. Robert J Wechsler-Reya Research Leadership The role of neural stem cells in cerebellar development, regeneration and tumorigenesis $5,226,049
Mohammad Pashmforoush Dr. Mohammad Pashmforoush New Faculty I Medical School Loan Repayment Program $27,949
Salk Institute for Biological Studies Dr. Dana Leanne Jones New Faculty I Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity $2,134,100
University of California, Los Angeles Dr. Dana Leanne Jones New Faculty I Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity $382,773
University of California, Los Angeles Dr. Siavash Kurdistani New Faculty I Epigenetics in cancer stem cell initiation and clinical outcome prediction $3,063,450
University of California, Santa Cruz Dr. Camilla Forsberg New Faculty I Mechanisms of Stem Cell Fate Decisions $2,201,759
1 2 3 4 5 6 7 8 9 10 11 … 29